Smoking and Surgery: Why Surgeons Ask You to Quit

Before most elective surgeries, the surgeon asks whether you smoke. This is not a lifestyle question. It is a risk assessment. Smokers have measurably higher rates of wound complications, respiratory problems, cardiovascular events and longer hospital stays [2]. A Cochrane review of preoperative cessation programs confirmed that quitting before surgery reduces postoperative complications [1]. The size of the effect is large enough that some surgical teams now consider preoperative cessation a standard part of preparation, alongside fasting instructions and medication adjustments.

What smoking does to surgical outcomes

The mechanisms are specific and well-characterized. Smoking affects nearly every system that matters for surgical recovery, and the effects are cumulative rather than isolated.

Wound healing. Nicotine causes vasoconstriction, reducing blood flow to tissues at the surgical site. Carbon monoxide binds to hemoglobin with an affinity roughly 200 times greater than oxygen, reducing the oxygen-carrying capacity of the blood. Together, these impair the oxygen delivery that wound healing requires at every stage: the initial inflammatory response, the formation of new blood vessels, and the deposition of collagen that gives the wound its strength [2].

Smokers have higher rates of wound infection, wound dehiscence (the surgical incision opening after closure), and delayed healing. The effect is not subtle. A review of the evidence found that smokers have significantly elevated rates of surgical site infection across a range of procedures, from orthopedic to abdominal to plastic surgery [2]. The wound healing impairment is particularly relevant for surgeries that require skin flaps or grafts, where blood supply to the transferred tissue is already compromised by the procedure itself. Adding smoking-related vasoconstriction to a tissue flap with a marginal blood supply can mean the difference between a successful graft and tissue necrosis.

Respiratory complications. Smokers have increased mucus production, impaired mucociliary clearance (the mechanism by which the airways clear secretions and debris), and airway hyperreactivity. After surgery, particularly abdominal or thoracic procedures, this translates to higher rates of pneumonia, atelectasis (partial lung collapse), and the need for prolonged mechanical ventilation [4]. General anesthesia itself suppresses cough reflexes and mucociliary function temporarily; in a smoker whose baseline clearance is already impaired, the combination creates a longer window of vulnerability for respiratory infection.

The respiratory risk is especially relevant for surgeries that require general anesthesia with intubation. The airway irritation from years of smoke exposure makes the trachea and bronchi more reactive to the endotracheal tube, increasing the risk of coughing, laryngospasm, or bronchospasm during the procedure. These are manageable complications in experienced hands, but they add time and risk to the anesthesia management.

Cardiovascular events. The combination of nicotine-driven increases in heart rate and blood pressure with carbon monoxide-reduced oxygen delivery creates cardiovascular stress under baseline conditions. Under the added physiological stress of anesthesia and surgery, including fluid shifts, blood loss, and the metabolic demands of tissue repair, this increases the risk of cardiac events [4]. Smokers’ blood also has higher levels of fibrinogen and increased platelet aggregation, which elevate the risk of postoperative thrombotic events, including deep vein thrombosis and pulmonary embolism.

Bone healing. For orthopedic procedures, smoking impairs bone healing through the same vascular mechanisms that affect soft tissue. Smokers have higher rates of nonunion (fractures that fail to heal) and delayed union after orthopedic surgery. This is well-documented in spinal fusion surgery, where smoking is one of the strongest modifiable risk factors for fusion failure [2].

Anesthesia management. Smokers have increased airway reactivity during intubation, higher risk of laryngospasm and bronchospasm, and altered metabolism of some anesthetic agents [4]. The hepatic enzyme induction caused by polycyclic aromatic hydrocarbons in cigarette smoke (not nicotine itself) means that smokers may metabolize certain drugs faster, requiring dosing adjustments. These effects are manageable for an experienced anesthesia team but add complexity and narrow the margin of safety.

How much quitting time matters

The evidence supports a dose-response relationship between preoperative cessation duration and complication reduction. This is one of the clearest findings in the surgical cessation literature: more time quit before surgery means better outcomes, and the benefit begins almost immediately.

Cessation period	What improves
12-24 hours	Carbon monoxide levels normalize; oxygen delivery improves
2-4 weeks	Respiratory function begins improving; airway reactivity decreases
4-8 weeks	Wound healing capacity improves; immune function recovers; complication rates significantly reduced
8+ weeks	Maximum preoperative benefit achieved

A Swedish RCT found that 4 weeks of cessation with NRT support reduced overall complication rates from 41% to 21% [5]. That is a reduction of roughly half, achieved with a relatively brief intervention. A meta-analysis found that each additional week of preoperative cessation improved outcomes [3]. The Cochrane review found that intensive interventions initiated at least 4 weeks before surgery significantly reduced complications, while less intensive interventions or those started closer to the surgery date had smaller effects [1].

The 4-week mark appears to be a meaningful threshold. Before that point, the cardiovascular benefits (carbon monoxide clearance, reduced heart rate and blood pressure) are already present, but the wound healing and immune function improvements are still accumulating. After 4 weeks, the evidence for reduced complication rates becomes consistently significant across studies. After 8 weeks, most of the recoverable physiological parameters have normalized, and the preoperative benefit plateaus.

The “brief abstinence” question

A concern raised in older literature was that very brief abstinence (less than 2 weeks) might temporarily increase respiratory complications due to increased mucus production as cilia recover. The reasoning was that recovering cilia produce more sputum before they can clear it efficiently, potentially increasing the risk of postoperative respiratory events. This created a temporary paradox in the surgical literature: some clinicians argued that quitting too close to surgery might be worse than continuing to smoke.

The current evidence does not support this as a reason to delay surgery or to avoid brief preoperative cessation. Even short abstinence provides cardiovascular benefits (carbon monoxide clearance, reduced heart rate) and does not appear to increase net risk compared to continued smoking [3]. The mucus increase is transient, and the cardiovascular improvements outweigh any short-term respiratory inconvenience. No modern surgical guideline recommends continued smoking over brief abstinence, regardless of the interval to surgery.

NRT in the preoperative period

Nicotine replacement therapy is safe to use before surgery. The surgical concern with smoking is primarily about carbon monoxide, combustion products, and the combination of multiple toxic exposures, not about nicotine alone. NRT provides nicotine without the combustion products, making it an appropriate tool for managing cravings during preoperative abstinence [1] [5].

Some surgical teams have historically been cautious about NRT before surgery due to nicotine’s vasoconstrictive effects. The current evidence and guideline position is that NRT is safer than continued smoking and should be offered as part of preoperative cessation support. The vasoconstrictive effect of nicotine delivered by a patch is substantially less than the combined vasoconstrictive and oxygen-reducing effect of smoking a cigarette, because the patch delivers a lower, steadier dose and does not deliver carbon monoxide at all.

The practical approach for most patients is to start NRT at the time of the quit date and continue through the surgical period. The patch provides a steady baseline dose; gum or lozenges can handle breakthrough cravings. For patients already using NRT as part of a longer quit attempt, no change is needed before surgery: the NRT continues as planned.

Choosing a cessation method for the preoperative period

The preoperative window is a distinct cessation context. The quit has a specific, external motivation (the surgery), a defined start date (whenever the smoker decides to stop), and a medical team that is invested in the outcome. This combination often produces higher motivation and better adherence than quit attempts without such a concrete trigger.

Method	Preoperative considerations
NRT (patch plus gum or lozenge)	Safe in the preoperative period; manages withdrawal without combustion products; available over the counter
Varenicline	Strongest single-method evidence; requires prescription and a 1-2 week titration period; start early enough to reach full dose before the quit date
Bupropion	Useful if the patient has co-occurring depression or anxiety; requires prescription and 1-2 week lead time
Cold turkey	Lower success rate but viable for shorter preoperative windows; the surgical motivation may offset the lower efficacy

For surgeries scheduled 6 or more weeks out, there is time to start varenicline or bupropion if the patient prefers a prescription approach. For surgeries within 2-4 weeks, NRT is the most practical option because it can begin immediately without a titration period.

What this means if you’re deciding

If you have elective surgery scheduled, the strongest evidence supports quitting at least 4 weeks before the procedure, ideally 8 weeks. NRT can help manage this period. If surgery is sooner than 4 weeks, quitting is still beneficial: carbon monoxide clears within hours, and cardiovascular improvements begin immediately. Every day of abstinence before surgery is better than none, even if the optimal window has passed.

For smokers with COPD facing surgery, the preoperative cessation window is especially important. COPD already compromises respiratory reserve, and smoking further reduces the margin of safety for anesthesia and postoperative recovery. Combination NRT or varenicline can support the preoperative quit attempt, and the medical team managing the surgery can coordinate with the cessation support.

For emergency surgery, preoperative cessation is not possible, but the surgical team will manage the increased risk with adjusted anesthesia planning and postoperative respiratory support. Postoperative cessation still improves recovery and reduces complication risk from that point forward. The hospitalization itself can serve as a forced abstinence period, and starting NRT in the hospital can support the transition to a sustained quit.

Open questions

Whether e-cigarettes carry the same surgical risks as combustible cigarettes is not well established. E-cigarettes deliver nicotine without carbon monoxide and most combustion products, but their effects on wound healing and perioperative risk have not been studied in adequate trials. The aerosol contains compounds that may have independent effects on tissue repair and immune function, but these are not yet characterized well enough to quantify the surgical risk. The current recommendation is to treat them similarly to NRT for preoperative risk assessment, while acknowledging the evidence gap.

Whether very long-term smokers (30 or more pack-years) benefit from preoperative cessation to the same degree as lighter smokers is not fully resolved. The structural lung damage and vascular changes from decades of smoking do not reverse in 4 to 8 weeks. The improvements that occur in that window are primarily functional (better oxygen delivery, reduced airway reactivity, improved immune response) rather than structural. For long-term heavy smokers, the preoperative benefit is still real but smaller than for someone who has smoked for a few years.

A doctor or pharmacist can help choose the right approach for your health history. The Quitline (1-800-QUIT-NOW) provides free coaching and can sometimes supply NRT.